Health Care Roundup: Market Talk
Dow Jones2026/10/14 16:20The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.
0451 ET - Whether European consumer goods companies can win the U.S. customer has become a central key investment debate for the sector, analysts at Barclays say in a note. U.S. consumers are becoming increasingly important for the industry--whether it be Danone's U.S. essential-dairy and plant-based recovery or Haleon's and Reckitt's cold and flu products. The ever-more demanding environment of the U.S. means that investment debates are increasingly focused on the country, the analysts say. (aimee.look@wsj.com)
0159 ET - Cochlear's scale, established clinic relationships and large recipient base should limit any near-term disruption from the launch of a new sound processor by hearing-implant rival Advanced Bionics, Jefferies analyst David Stanton says. Stanton writes in a note that the Integro CI sound processor from Sonova-owned Advanced Bionics could modestly constrain Australia-listed Cochlear's share of processor upgrades and new system wins in selected European markets. Ultimately, he sees Integro as a product that could support gradual market-share stabilization or gains for Sonova, rather than rapid losses for Cochlear. Jefferies has a hold rating on Cochlear shares and a target price of 144.75 Australian dollars. Shares closed 0.2% lower at A$129.28. (stuart.condie@wsj.com)
2010 ET - EBR Systems' bull at Bell Potter thinks the wireless pacemaker developer will need to raise more capital than previously envisioned. Analyst Martyn Jacobs had already anticipated a capital raise in mid-2027, but tells clients in a note that disappointing sales suggest the company will need additional equity after that. He lowers his fiscal 2026 sales forecast by 21% to US$10.8 million, and cuts volume expectations through his forecast period. Bell Potter keeps a speculative buy rating on the stock but slashes its target price by 71% to 0.20 Australian dollars. Shares are up 3.2% at A$0.16. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
October 14, 2026 12:20 ET (16:20 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Energy Earnings Week Kicks Off: Marathon Petroleum (MPC.US) Profit Doubles as Opening Act, Political Criticism Looms
Energy giant earnings week approaches: ExxonMobil and others are expected to see their EPS double, while BTIG warns that the refining index, after surging 160%, may retreat.
Roblox (RBLX.US) Q3 daily active users fall short of expectations: ongoing pain from child safety restructuring, stock plunges over 17% after hours
Roblox’s Q3 daily active users reached 138 million, falling short of expectations, while bookings exceeded forecasts at 1.7 billion USD. However, weak Q4 guidance combined with the drag from child safety rectifications led to a plunge of over 12% in after-hours trading.
Vale (VALE.US) Q3 Net Profit Halved Year-on-Year to $1.26 Billion; Both Iron Ore Volume and Price Fell, But Revenue Still Surpassed Expectations
One of the world's largest iron ore producers, Vale, reported a significant 53% year-on-year decline in net profit for the third quarter of 2026, dragged down by lower realized iron ore prices and rising freight costs, falling short of market expectations.
Crypto prices
More
